AFRIMS Armed Forces Research Institute of Medical Sciences
  • About AFRIMS
  • News
  • Publications
  • Locations / Facilities
  • Contact Us
Left navigator bar NewComer Information Check E-mail Hman Subjects Protection Information Management Resource Management Research Support Logistics Library Epidemiology and Disease Surveillance Human Resources Veterinary Medicine Virology Embassy of the United States, Bangkok Retrovirology JUSMAG Immunology Entomology Enteric Diseases AKO (Army Knowledge Online) Senior NCO RTA-AFRIMS WHO Collaborating Center Director WRAIR iSalute
recent publications

Retrovirology

    2013
  1. Akapirat S; Avihingsanon A; Ananworanich J; Schuetz A; Ramasoota P; Luplertlop N; Ono K; Ikuta K; Utachee P; Kameoka M; Leaungwutiwong P. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais. Southeast Asian J Trop Med Public Health 2013 Sep; 44(5):825-41
  2. Alam SM; Liao HX; Tomaras GD; Bonsignori M; Tsao CY; Hwang KK; Chen H; Lloyd KE; Bowman C; Sutherland L; Jeffries TL Jr; Kozink DM; Stewart S; Anasti K; Jaeger FH; Parks R; Yates NL; Overman RG; Sinangil F; Berman PW; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Karasavva N; Rerks-Ngarm S; Kim JH; Michael NL; Zolla-Pazner S; Santra S; Letvin NL; Harrison SC; Haynes BF. Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion. J Virol 2013 Feb; 87(3):1554-68
  3. Ananworanich J; Fletcher JL; Pinyakorn S; van Griensven F; Vandergeeten C; Schuetz A; Pankam T; Trichavaroj R; Akapirat S; Chomchey N; Phanuphak P; Chomont N; Michael NL; Kim JH; de Souza M. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology 2013 May; 10:56
  4. Elizaga ML; Vasan S; Marovich MA; Sato AH; Lawrence DN; Chaitman BR; Frey SE; Keefer MC. Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review. PLoS One 2013 Jan; 8(1):e54407
  5. Gottardo R; Bailer RT; Korber BT; Gnanakaran S; Phillips J; Shen X; Tomaras GD; Turk E; Imholte G; Eckler L; Wenschuh H; Zerweck J; Greene K; Gao H; Berman PW; Francis D; Sinangil F; Lee C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Robb ML; Michael NL; Kim JH; Zolla-Pazner S; Haynes BF; Mascola JR; Self S; Gilbert P; Montefiori DC. Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial. PLoS One 2013 Sep; 8(9):e75665
  6. Kaewkungwal J; Pitisuttithum P; Rerks-Ngarm S; Nitayaphan S; Khamboonruang C; Kunasol P; Suntharasamai P; Pungpak S; Vanijanonta S; Bussaratid V; Maek-A-Nantawat W; Dhitavat J; Thongcharoen P; Pawarana R; Sabmee Y; Benenson MW; Morgan P; O'Connell RJ; Kim J. Issues in women's participation in a phase III community HIV vaccine trial in Thailand. AIDS Res Hum Retroviruses 2013 Nov; 29(11):1524-34
  7. Kijak GH; Tovanabutra S; Rerks-Ngarm S; Nitayaphan S; Eamsila C; Kunasol P; Khamboonruang C; Thongcharoen P; Namwat C; Premsri N; Benenson M; Morgan P; Bose M; Sanders-Buell E; Paris R; Robb ML; Birx DL; De Souza MS; McCutchan FE; Michael NL; Kim JH. Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial. J Virol 2013 Jul; 87(13):7265-81
  8. Liao HX; Bonsignori M; Alam SM; McLellan JS; Tomaras GD; Moody MA; Kozink DM; Hwang KK; Chen X; Tsao CY; Liu P; Lu X; Parks RJ; Montefiori DC; Ferrari G; Pollara J; Rao M; Peachman KK; Santra S; Letvin NL; Karasavvas N; Yang ZY; Dai K; Pancera M; Gorman J; Wiehe K; Nicely NI; Rerks-Ngarm S; Nitayaphan S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Sinangil F; Kim JH; Michael NL; Kepler TB; Kwong PD; Mascola JR; Nabel GJ; Pinter A; Zolla-Pazner S; Haynes BF. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 2013 Jan; 38(1):176-86
  9. Liu P; Yates NL; Shen X; Bonsignori M; Moody MA; Liao HX; Fong Y; Alam SM; Overman RG; Denny T; Ferrari G; Ochsenbauer C; Kappes JC; Polonis VR; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Rerks-Ngarm S; Montefiori DC; Gilbert P; Michael NL; Kim JH; Haynes BF; Tomaras GD. Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees. J Virol 2013 Jul; 87(14):7828-36
  10. Padte NN; Boente-Carrera M; Andrews CD; McManus J; Grasperge BF; Gettie A; Coelho-Dos-Reis JG; Li X; Wu D; Bruder JT; Sedegah M; Patterson N; Richie TL; Wong CH; Ho DD; Vasan S; Tsuji M. A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates. PLoS One 2013 Oct; 8(10):e78407
  11. Rerks-Ngarm S; Paris RM; Chunsutthiwat S; Premsri N; Namwat C; Bowonwatanuwong C; Li SS; Kaewkungkal J; Trichavaroj R; Churikanont N; de Souza MS; Andrews C; Francis D; Adams E; Flores J; Gurunathan S; Tartaglia J; O'Connell RJ; Eamsila C; Nitayaphan S; Ngauy V; Thongcharoen P; Kunasol P; Michael NL; Robb ML; Gilbert PB; Kim JH. Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. J Infect Dis 2013 Apr; 207(8):1195-205
  12. Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. J Med Virol 2013 Jul; 85(7):1170-9
  13. Valcour VG; Ananworanich J; Agsalda M; Sailasuta N; Chalermchai T; Schuetz A; Shikuma C; Liang CY; Jirajariyavej S; Sithinamsuwan P; Tipsuk S; Clifford DB; Paul R; Fletcher JL; Marovich MA; Slike BM; Degruttola V; Shiramizu B. HIV DNA reservoir increases risk for cognitive disorders in cART-naive patients. PLoS One 2013 Jul; 8(7):e70164
  14. Wieczorek L; Brown BK; Delsarto Macedo C; Wesberry-Schmierer M; Ngauy V; Rosa Borges A; Michael NL; Marovich MA; Montefiori DC; Polonis VR. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling. Virology 2013 Dec; 447(1-2):240-8
  15. Zolla-Pazner S; deCamp AC; Cardozo T; Karasavvas N; Gottardo R; Williams C; Morris DE; Tomaras G; Rao M; Billings E; Berman P; Shen X; Andrews C; O'Connell RJ; Ngauy V; Nitayaphan S; de Souza M; Korber B; Koup R; Bailer RT; Mascola JR; Pinter A; Montefiori D; Haynes BF; Robb ML; Rerks-Ngarm S; Michael NL; Gilbert PB; Kim JH. Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One 2013 Jan; 8(1):e53629
    2012
  1. Ananworanich J; Schuetz A; Vandergeeten C; Sereti I; de Souza M; Rerknimitr R; Dewar R; Marovich M; van Griensven F; Sekaly R; Pinyakorn S; Phanuphak N; Trichavaroj R; Rutvisuttinunt W; Chomchey N; Paris R; Peel S; Valcour V; Maldarelli F; Chomont N; Michael N; Phanuphak P; Kim JH. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012 Mar; 7(3):e33948
  2. Brown BK; Wieczorek L; Kijak G; Lombardi K; Currier J; Wesberry M; Kappes JC; Ngauy V; Marovich M; Michael N; Ochsenbauer C; Montefiori DC; Polonis VR. The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. PLoS One 2012 Apr; 7(4):e29454
  3. de Souza MS; Ratto-Kim S; Chuenarom W; Schuetz A; Chantakulkij S; Nuntapinit B; Valencia-Micolta A; Thelian D; Nitayaphan S; Pitisuttithum P; Paris RM; Kaewkungwal J; Michael NL; Rerks-Ngarm S; Mathieson B; Marovich M; Currier JR; Kim JH. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J Immunol 2012 May; 188(10):5166-76
  4. Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection. J Acquir Immune Defic Syndr 2012 Sep; 61(1):9-18
  5. Haynes BF; Gilbert PB; McElrath MJ; Zolla-Pazner S; Tomaras GD; Alam SM; Evans DT; Montefiori DC; Karnasuta C; Sutthent R; Liao HX; DeVico AL; Lewis GK; Williams C; Pinter A; Fong Y; Janes H; DeCamp A; Huang Y; Rao M; Billings E; Karasavvas N; Robb ML; Ngauy V; de Souza MS; Paris R; Ferrari G; Bailer RT; Soderberg KA; Andrews C; Berman PW; Frahm N; De Rosa SC; Alpert MD; Yates NL; Shen X; Koup RA; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Rerks-Ngarm S; Michael NL; Kim JH. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012 Apr; 366(14):1275-86
  6. Karasavvas N; Billings E; Rao M; Williams C; Zolla-Pazner S; Bailer RT; Koup RA; Madnote S; Arworn D; Shen X; Tomaras GD; Currier JR; Jiang M; Magaret C; Andrews C; Gottardo R; Gilbert P; Cardozo TJ; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Paris R; Greene K; Gao H; Gurunathan S; Tartaglia J; Sinangil F; Korber BT; Montefiori DC; Mascola JR; Robb ML; Haynes BF; Ngauy V; Michael NL; Kim JH; de Souza MS; for the MOPH TAVEG Collaboration. The Thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. AIDS Res Hum Retroviruses 2012 Nov; 28(11):1444-57
  7. Kopycinski J; Cheeseman H; Ashraf A; Gill D; Hayes P; Hannaman D; Gilmour J; Cox JH; Vasan S. A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the alpha4beta7-binding V2 loop of HIV gp120 in healthy volunteers. Clin Vaccine Immunol 2012 Sep; 19(9):1557-9
  8. Montefiori DC; Karnasuta C; Huang Y; Ahmed H; Gilbert P; de Souza MS; McLinden R; Tovanabutra S; Laurence-Chenine A; Sanders-Buell E; Moody MA; Bonsignori M; Ochsenbauer C; Kappes J; Tang H; Greene K; Gao H; LaBranche CC; Andrews C; Polonis VR; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kaewkungwal J; Self SG; Berman PW; Francis D; Sinangil F; Lee C; Tartaglia J; Robb ML; Haynes BF; Michael NL; Kim JH. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J Infect Dis 2012 Aug; 206(3):431-41
  9. Nitayaphan S; Ngauy V; O'Connell R; Excler JL. HIV epidemic in Asia: optimizing and expanding vaccine development. Expert Rev Vaccines 2012 Jul; 11(7):805-19
  10. Paris R; Bejrachandra S; Thongcharoen P; Nitayaphan S; Pitisuttithum P; Sambor A; Gurunathan S; Francis D; Ratto-Kim S; Karnasuta C; de Souza MS; Polonis V; Brown A; Kim J; Stephens H; for the Thai AIDS Vaccine Evaluation Group (TAVEG). HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX((R)) B/E. Vaccine 2012 Jan; 30(5):832-6
  11. Robb ML; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Kunasol P; Khamboonruang C; Thongcharoen P; Morgan P; Benenson M; Paris RM; Chiu J; Adams E; Francis D; Gurunathan S; Tartaglia J; Gilbert P; Stablein D; Michael NL; Kim JH. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect Dis 2012 Jul; 12(7):531-7
  12. Rolland M; Edlefsen PT; Larsen BB; Tovanabutra S; Sanders-Buell E; Hertz T; Decamp AC; Carrico C; Menis S; Magaret CA; Ahmed H; Juraska M; Chen L; Konopa P; Nariya S; Stoddard JN; Wong K; Zhao H; Deng W; Maust BS; Bose M; Howell S; Bates A; LazzaroO'Sullivan A; Lei E; Bradfield A; Ibitamuno G; Assawadarachai V; O'Connell RJ; Desouza MS; Nitayaphan S; Rerks-Ngarm S; Robb ML; McLellan JS; Georgiev I; Kwong PD; Carlson JM; Michael NL; Schief WR; Gilbert PB; Mullins JI; Kim JH. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 2012 Oct 18; 490(7420):417-20
  13. Rutvisuttinunt W; Arroyo MA; Assawadarachai V; Poltavee K; McCutchan FE; Tovanabutra S; Kijak G; Kim JH; Paris RM; de Souza M. Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience. Southeast Asian J Trop Med Public Health 2012 Mar; 43(2):333-9
  14. Rutvisuttinunt W; Sirivichayakul S; Oota S; Assawadarachai V; Poltavee K; Savadsuk H; Pattanachaiwit S; Chaemchuen S; Arroyo MA; Paris RM; Michael NL; Kim JH; Ruxrungtham K; de Souza M; Phanuphak P; Tovanabutra S. Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors. AIDS Res Hum Retroviruses 2012 Dec; 28(12):1703-11
  15. Sailasuta N; Ross W; Ananworanich J; Chalermchai T; DeGruttola V; Lerdlum S; Pothisri M; Busovaca E; Ratto-Kim S; Jagodzinski L; Spudich S; Michael N; Kim JH; Valcour V. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One 2012 Nov; 7(11):e49272
  16. Steers NJ; Ratto-Kim S; de Souza MS; Currier JR; Kim JH; Michael NL; Alving CR; Rao M. HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses. PLoS One 2012 Aug; 7(8):e42579
  17. Valcour V; Chalermchai T; Sailasuta N; Marovich M; Lerdlum S; Suttichom D; Suwanwela NC; Jagodzinski L; Michael N; Spudich S; van Griensven F; de Souza M; Kim J; Ananworanich J. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 2012 Jul; 206(2):275-82
  18. Vasan S; Michael NL. Improved outlook on HIV-1 prevention and vaccine development. Expert Opin Biol Ther 2012 Aug; 12(8):983-94
    2011
  1. Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans. PLoS One 2011 Apr; 6(4):e18779
  2. Eller MA; Koehler RN; Kijak GH; Eller LA; Guwatudde D; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK. Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in Ugandans carrying the HLA-B Bw4 motif. J Virol 2011 May; 85(10):4802-11
  3. Leaungwutiwong P; Ittiprasert W; Saikhun K; Tong-ngam P; Akapirat S; Chattanadee S; Kitiyanant Y. Impairment of CD4+CD25+ regulatory T cells in C4-deficient mice. Asian Pac J Allergy Immunol 2011 Sep; 29(3):220-8
  4. Nanda K; Morrison CS; Kwok C; Byamugisha J; Jones L; Sriplienchan S; Magwali T. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception 2011 Jun; 83(6):542-8
  5. Oballah P; Flach B; Eller LA; Eller MA; Ouma B; de Souza M; Kibuuka HN; Wabwire-Mangen F; Brown BK; Michael NL; Robb ML; Montefiori D; Polonis VR. B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses. PLoS One 2011 Aug; 6(8):e22653
  6. Pitisuttithum P; Rerks-Ngarm S; Bussaratid V; Dhitavat J; Maekanantawat W; Pungpak S; Suntharasamai P; Vanijanonta S; Nitayapan S; Kaewkungwal J; Benenson M; Morgan P; O'Connell RJ; Berenberg J; Gurunathan S; Francis DP; Paris R; Chiu J; Stablein D; Michael NL; Excler JL; Robb ML; Kim JH. Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand. PLoS One 2011 Dec; 6(12):e27837
  7. Pitisuttithuml P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashirob H; Manrique A; Bernstein A; Goya R; Ditangco RA; Cooperlo DA; Osmanovll S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Yiming Shaolb for the AIDS Vaccine for Asia Network. Accelerating the development of an AIDS vaccine: the AIDS Vaccine for Asia Network (AVAN). Southeast Asian J Trop Med Public Health 2011 Sep; 42(5):1130-46
  8. The Ministry of Public Health - Thai AIDS Vaccine Evaluation Group (MOPH-TAVEG); (MOPH-TAVEG Collaboration: ; Rerks-Ngarm S; Chunsuttiwat S; Premsri N; Namwat C; Kunasol P; Thongcharoen P; Khamboonruang C; Pitisuttithum P; Bussaratid V; Maek-a-nantawat W; Dhitavat J; Suntharasamai P; Pungpak S; Vanijanonta S; Kaewkungwal J; Khamsiriwatchara A; Jarujareet P; Nitayaphan S; Easmila C; Tabprasit S; Paris R; Benenson M; Morgan P; de Souza M; Brown AE; Trichavaroj R; Gurunathan S; Tartaglia J; McNeil JG; Francis D; Heyward W; Gurwith M; Chiu J; Kim JH; Robb ML; Michael NL; Birx DL; Bolen A). Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148). Vaccine 2011 Jun; 29(25):4285-92
    2010
  1. Aramaki M; Silachamroon U; Desakorn V; Maek-A-nantawat W; Waiwaruwut J; Jutiwarakun K; Kim JH; Pitisuttithum P. Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand. Southeast Asian J Trop Med Public Health 2010 Jan; 41(1):138-45
  2. Arroyo MA; Phanuphak P; Krasaesub S; Sirivichayakul S; Assawadarachai V; Poltavee K; Pankam T; Ananworanich J; Paris R; Tovanabutra S; Kijak GH; McCutchan FE; Phanuphak P; Kim JH; de Souza M. HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. AIDS Res Hum Retroviruses 2010 Jan; 26(1):5-12
  3. Brown AE; Sirisanthana T. Anthrax (7.6.20 section 7 Infection). In: Oxford textbook of medicine edited by David A. Warrell, Timothy M. Cox, and John D. Firth. 5th ed. Oxford : Oxford University Press, 2010:783-8
  4. Chuenchitra T; Sukwit S; Chaitaveep P; Kuvanont S; Amlee P; Songprasom K; Tabprasit S; De Souza M; Srisurapanon S; Sirisopana N; Nitayaphan S. A whole blood lymphocyte proliferation assay in healthy Thais: comparison of heparinized blood and acid citrate dextrose blood. J Med Assoc Thai 2010 Feb; 93 Suppl 2:S21-6
  5. Currier JR; Ngauy V; de Souza MS; Ratto-Kim S; Cox JH; Polonis VR; Earl P; Moss B; Peel S; Slike B; Sriplienchan S; Thongcharoen P; Paris RM; Robb ML; Kim J; Michael NL; Marovich MA. Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate. PLoS One 2010 Nov; 5(11):e13983
  6. Kibuuka H; Kimutai R; Maboko L; Sawe F; Schunk MS; Kroidl A; Shaffer D; Eller LA; Kibaya R; Eller MA; Schindler KB; Schuetz A; Millard M; Kroll J; Dally L; Hoelscher M; Bailer R; Cox JH; Marovich M; Birx DL; Graham BS; Michael NL; de Souza MS; Robb ML. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-uninfected East Africans (RV172). J Infect Dis 2010 Feb; 201(4):600-607
  7. Olemukan RE; Eller LA; Ouma BJ; Etonu B; Erima S; Naluyima P; Kyabaggu D; Cox JH; Sandberg JK; Wabwire-Mangen F; Michael NL; Robb ML; de Souza MS; Eller MA. Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting. Clin Vaccine Immunol 2010 Jun; 17(6):910-8
  8. Paris RM; Kim JH; Robb ML; Michael NL. Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. Expert Rev Vaccines 2010 Sep; 9(9):1055-69
  9. Pumpradit W; Ananworanich J; Lolak S; Shikuma C; Paul R; Siangphoe U; Chaoniti N; Kaew-On P; Paris R; Ruxrungtham K; Valcour V. Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN cohort study. J Neurovirol 2010 Feb; 16(1):76-82
    2009
  1. Alter G; Ananworanich J; Pantophlet R; Rybicki EP; Buonaguro L. Report on the AIDS Vaccine 2008 Conference. Hum Vaccin 2009 Mar; 5(3):119-25
  2. Arroyo MA; Sateren WB; Foglia G; Kibaya R; Langat L; Wasunna M; Bautista CT; Scott PT; Shaffer DN; Robb ML; Michael NL; Birx DL; McCutchan FE. Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya. AIDS Res Hum Retroviruses 2009 Nov; 25(11):1061-4
  3. Birx D; de Souza M; Nkengasong JN. Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery. Am J Clin Pathol 2009 Jun; 131(6):849-51
  4. Eller MA; Eller LA; Ouma BJ; Thelian D; Gonzalez VD; Guwatudde D; McCutchan FE; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK. Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J Acquir Immune Defic Syndr 2009 Aug; 51(4):380-9
  5. Rerks-Ngarm S; Pittisutthithum P; Nitayaphan S; Kaewkungwal J; Chiu J; Paris R; Premsri N; Namwat C; de Souza M; Adams E; Benenson M; Gurunathan S; Tartaglia J; McNeil JG; Francis DP; Stablein D; Birx DL; Chunsuttiwat S; Khamboonruang C; Thongcharoen P; Robb ML; Michael NL; Kunasol P; Kim JH; The MOPH-TAVEG collaborators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009 Dec; 361(23):2209-20
  6. Simek MD; Rida W; Priddy FH; Pung P; Carrow E; Laufer DS; Lehrman JK; Boaz M; Tarragona-Fiol T; Miiro G; Birungi J; Pozniak A; McPhee DA; Manigart O; Karita E; Inwoley A; Jaoko W; Dehovitz J; Bekker LG; Pitisuttithum P; Paris R; Walker LM; Poignard P; Wrin T; Fast PE; Burton DR; Koff WC. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol 2009 Jul; 83(14):7337-48
  7. Valcour VG; Shiramizu BT; Sithinamsuwan P; Nidhinandana S; Ratto-Kim S; Ananworanich J; Siangphoe U; Kim JH; de Souza M; Degruttola V; Paul RH; Shikuma CM; [on behalf of For the Southeast Asia Research Collaboration with the University of Hawaii (SEARCH) 001 protocol team]. HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 2009 Mar; 72(11):992-8
Back to Retrovirology Department
Recent Activities at AFRIMS
AFRIMS recent activities HIV Vaccine Study First to show effectiveness AFRIMS on Dengue at Voice of America AFRIMS on Malaria in New York Times AFRIMS researchers instructed 104 medical cadets from Phramongkutklao College of Medicine AFRIMS hosts infectious diseae surveillance workshop for laos PDR lab technicians AFRIMS concludes Pilat Malaria Prophylaxis clinical trial in Cambodia Dr. Rampa Rattanarathiul received the Belkin Award, The highest honor given by the AMCA Dedication and opening of joint AFPMC AFRIMS molecular laboratory in the Phillippines NBC shows story on drug resistant malaria on the Thai-Cambodia border in Cambodia Malaria Vaccine: Inside look at first human trial from BBC news HVRC opening ceremony Change of Command 2015 AFRIMS leaders join "Bike For Mom 2015" event US Embassy Employee of the Month Public Release of Joint Concept of Health Services Public Release of Joint Concept of Health Services more AFRIMS activities